Skip to main content
Charles Cantor, MD, Neurology, Philadelphia, PA

CharlesRCantorMD

Neurology Philadelphia, PA

Sleep Medicine

Associate Professor, Neurology, Perelman School of Medicine

Dr. Cantor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Cantor's full profile

Already have an account?

  • Office

    3400 Civic Center Blvd
    Fl 2
    Philadelphia, PA 19104
    Phone+1 215-662-3606
    Fax+1 215-243-2312

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Neurology, 1987 - 1990
  • St Elizabeth's Medical Center
    St Elizabeth's Medical CenterInternship, Internal Medicine, 1986 - 1987
  • University of Massachusetts Medical School
    University of Massachusetts Medical SchoolClass of 1986

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1987 - 2024
  • NJ State Medical License
    NJ State Medical License 1996 - 2001
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Journal Articles

  • miR-34a Directly Targets tRNAiMet Precursors and Affects Cellular Proliferation, Cell Cycle, and Apoptosis  
    Charles R Cantor, Arul M Chinnaiyan, Proceedings of the National Academy of Sciences

Press Mentions

  • Potential IPF Treatment, Found Using AI, May Move into Trial, Insilico Says
    Potential IPF Treatment, Found Using AI, May Move into Trial, Insilico SaysMarch 2nd, 2021
  • Breaking Big Pharma's AI Barrier: Insilico Medicine Uncovers Novel Target, New Drug for Pulmonary Fibrosis in 18 Months
    Breaking Big Pharma's AI Barrier: Insilico Medicine Uncovers Novel Target, New Drug for Pulmonary Fibrosis in 18 MonthsFebruary 24th, 2021
  • Novel Molecules Designed by Artificial Intelligence in 21 Days Are Validated in Mice
    Novel Molecules Designed by Artificial Intelligence in 21 Days Are Validated in MiceSeptember 3rd, 2019
  • Join now to see all

Grant Support

  • Engineered Microogranisms For In Situ RemediationNational Center For Environmental Health1999
  • Enhanced Hybridization For High Throughput DNA SequencingNational Center For Research Resources1997
  • Enhanced Hybridization For Throughput DNA SequencingNational Center For Research Resources1996
  • Gene Structure, Arrangement, Dynamics, And ExpressionNational Cancer Institute1991
  • Gene Structure, Arrangement, Dynamics, And ExpressionNational Cancer Institute1989–1991
  • New Techniques For Complex Macromoplecular AssembliesNational Institute Of General Medical Sciences1989
  • New Techniques For Complex Macromolecular AssembliesNational Institute Of General Medical Sciences1985–1989
  • Gene Structure, Arrangement, Dynamics, And ExpressionNational Cancer Institute1985–1988
  • Cell Molecular And Developmental Biology Of CancerNational Cancer Institute1985–1988
  • Structural Organization Of Ribosomes And Large RNASNational Institute Of General Medical Sciences1985–1986